NCT03995927

Brief Summary

The proposed study represents a quality improvement study of a recently-developed dedicated radiation oncology subspecialty clinic with the goal of improving timeliness of palliative radiation therapy and improving resident training in palliative care topics. The aim of this study is to evaluate the impact of this clinic on time to palliative radiation therapy following referral.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 20, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 24, 2019

Completed
21 days until next milestone

Study Start

First participant enrolled

July 15, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 28, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 5, 2020

Completed
Last Updated

June 29, 2023

Status Verified

June 1, 2023

Enrollment Period

7 months

First QC Date

June 20, 2019

Last Update Submit

June 27, 2023

Conditions

Keywords

Difficult to treat cancers

Outcome Measures

Primary Outcomes (1)

  • Number of Days Between Referral and Start of Treatment

    Number of days between referral to palliative radiation therapy interval and start of palliative radiation therapy compared to historical control. Mean time from referral to the start of RT (measured in days) will be computed for our sample and compared to the historical control mean of 13.4 days using a two-sided one-sample t-test.

    3 months

Secondary Outcomes (5)

  • Mean Time from Referral for Consultation

    3 months

  • Mean Time from Consultation to CT Simulation

    3 months

  • Mean Time from CT Simulation to Palliative Radiation Start

    3 months

  • Quality of Life Changes

    1 and 3 months after treatment completion

  • Overall Survival

    6 months after treatment completion

Study Arms (1)

Data collection/questionnaire

Data collection for patient medical charts and patient fill out questionnaires first visit and post-treatment visits

Other: Data collection and analysisOther: Quality of Life Questionnaire

Interventions

Only radiation oncology patients data from medical records regarding treatment, demographics and follow-up visits will be collected and logged by investigators.

Data collection/questionnaire

Participants will be asked to complete a set of short forms at first visit and post-treatment visits. If participant has a routine visit about 3 months after treatment, participant will be asked to complete a final form that is optional.

Data collection/questionnaire

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population will be comprised of patients referred to radiation oncology for consideration of palliative radiation therapy

You may qualify if:

  • Age 18 years or older
  • Clinically or pathologically-defined malignant disease amenable to palliative radiotherapy.

You may not qualify if:

  • Pregnancy. A verbal pregnancy denial will suffice.
  • No intention to treat with palliative radiation therapy following initial referral and consult.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wake Forest Baptist Comprehensive Cancer Center

Winston-Salem, North Carolina, 27157, United States

Location

MeSH Terms

Conditions

Neoplasm Metastasis

Interventions

Data Collection

Condition Hierarchy (Ancestors)

Neoplastic ProcessesNeoplasmsPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Doris Brown, MD, PhD

    Wake Forest University Health Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 20, 2019

First Posted

June 24, 2019

Study Start

July 15, 2019

Primary Completion

January 28, 2020

Study Completion

April 5, 2020

Last Updated

June 29, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations